Actos® FDA Warnings
On June 15, 2011, the U.S. Food and Drug Administration (FDA) released a warning stating that pioglitazone, a drug designed to treat Type 2 diabetes, could cause an increased risk of bladder cancer if used for more than one year. Because of this risk, the FDA requires drug manufacturers to add warning labels (FDA warnings) to all drugs containing pioglitazone, including Actos®, ActoplusMet®, and Duetact®.
At Ferrer, Poirot & Wansbrough, we’re dedicated to helping people who have been injured by medications like Actos. If you or someone you love developed bladder cancer or another serious illness after taking a drug containing pioglitazone, our Actos side effects lawyers want to help you get compensation for your medical bills and other expenses. Just dial (800) 210-8503 or fill out a free initial consultation form.
List of Actos® Precautions
The FDA published a list of precautions for Actos use, including:
- Bladder Cancer Risk
The FDA warns doctors not to prescribe Actos to patients with active bladder cancer or a history of bladder cancer. Patients with these conditions who take Actos may have their conditions worsen, or their cancers may return.
- Congestive Heart Failure
Actos use has been linked to congestive heart failure in some patients. As a result, the FDA requires the manufacturers of Actos and other drugs containing pioglitazone to add stronger warnings for risks of heart failure on the labels of their medications.
These conditions require expensive medical treatments to alleviate symptoms. Ferrer, Poirot & Wansbrough wants to protect your rights to the compensation you deserve if you’ve been injured by Actos.
We Want to Help You
We’ve fought for the rights of thousands of injured clients since 1981. Now let our Actos injury lawyers help you get the money you deserve. Don’t wait another day to get our experienced legal help on your side—contact Ferrer, Poirot & Wansbrough today.
Actos®, ActoplusMet®, and Duetact® are registered trademarks of Takeda Pharmaceutical Company Limited.
This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or Takeda Pharmaceutical Company Limited.